Featured ArticlesJDD in the Media

How to Get Rid of Dry Skin

Dermatology News

Featured Article

Colloidal oat extracts exhibit anti-inflammatory activities, which may provide the mechanisms for observed dermatological benefits when using the colloidal oatmeal in skin protectant lotion.

Read Article Now

"How to Get Rid of Dry Skin"

Dry skin is a common complaint, with many dermatology patients seeking treatments for itching, irritation, and tightness. Severe dry skin can lead to cracked skin and bleeding.
While there are many topical agents to combat dry skin, including scent-free lotions, emollients, and creams, one tried-and-true remedy is making a comeback.

Insider.com‘s recent feature, “How to Get Rid of Dry Skin,” cites JDD research on oatmeal’s efficacy in combating dry, irritated skin ( “Anti-inflammatory Activities of Colloidal Oatmeal (Avena Sativa) Contribute to the Effectiveness of Oats in Treatment of Itch Associated With Dry, Irritated Skin” )

A 2015 study published in the Journal of Drugs in Dermatology showed that colloidal oatmeal (which is essentially oats that have been finely ground down) is effective at reducing skin dryness, roughness, and itchiness. This is because oatmeal helps repair the skin barrier, is anti inflammatory, and has antioxidant properties […].

Moreover, colloidal oat extracts exhibit anti-inflammatory activities, which may provide the mechanisms for observed dermatological benefits when using the colloidal oatmeal in skin protectant lotion.

Topical Applications of Oatmeal

Discover more research on oatmeal’s anti-inflammatory, anti-oxidant properties and applications in a variety of skin conditions.

JDD Article Referenced in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair

An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair

| Featured Articles, Hair, Latest News, The Latest | No Comments
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Journal of Drugs in Dermatology JDD Article About SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics, The Latest | No Comments
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Journal of Drugs in Dermatology JDD Article About Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

| Atopic Dermatitis, Featured Articles, Latest News, Pediatrics, The Latest | No Comments
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…

Leave a Reply